1. Home
  2. DNOW vs ADPT Comparison

DNOW vs ADPT Comparison

Compare DNOW & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • ADPT
  • Stock Information
  • Founded
  • DNOW 1862
  • ADPT 2009
  • Country
  • DNOW United States
  • ADPT United States
  • Employees
  • DNOW N/A
  • ADPT N/A
  • Industry
  • DNOW Metal Fabrications
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DNOW Industrials
  • ADPT Health Care
  • Exchange
  • DNOW Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • DNOW 2.3B
  • ADPT 2.6B
  • IPO Year
  • DNOW N/A
  • ADPT 2019
  • Fundamental
  • Price
  • DNOW $13.95
  • ADPT $20.36
  • Analyst Decision
  • DNOW Strong Buy
  • ADPT Strong Buy
  • Analyst Count
  • DNOW 3
  • ADPT 10
  • Target Price
  • DNOW $17.33
  • ADPT $16.60
  • AVG Volume (30 Days)
  • DNOW 3.2M
  • ADPT 2.4M
  • Earning Date
  • DNOW 11-05-2025
  • ADPT 11-05-2025
  • Dividend Yield
  • DNOW N/A
  • ADPT N/A
  • EPS Growth
  • DNOW N/A
  • ADPT N/A
  • EPS
  • DNOW 0.87
  • ADPT N/A
  • Revenue
  • DNOW $2,432,000,000.00
  • ADPT $252,754,000.00
  • Revenue This Year
  • DNOW $5.86
  • ADPT $36.43
  • Revenue Next Year
  • DNOW $3.22
  • ADPT $12.31
  • P/E Ratio
  • DNOW $16.04
  • ADPT N/A
  • Revenue Growth
  • DNOW 3.18
  • ADPT 42.57
  • 52 Week Low
  • DNOW $12.01
  • ADPT $4.76
  • 52 Week High
  • DNOW $18.45
  • ADPT $20.76
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 53.97
  • ADPT 73.37
  • Support Level
  • DNOW $12.01
  • ADPT $13.28
  • Resistance Level
  • DNOW $13.41
  • ADPT $14.24
  • Average True Range (ATR)
  • DNOW 0.66
  • ADPT 1.19
  • MACD
  • DNOW 0.13
  • ADPT 0.57
  • Stochastic Oscillator
  • DNOW 77.31
  • ADPT 95.19

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: